**1. Introduction**

PV has established itself as a huge and dynamic working field for health-related workers since it involves major fields like operations, surveillance, systems and qualified person for pharmacovigilance. Each field has a complex but interrelated role.

PV is the call for the era since the clinical trials are increasing in number day by day, and the safety concerns for drugs are becoming larger and larger. PV is an immediate requirement for every country for the following reasons:


The above factors make PV more significant as there is voluminous data to be reported, collected and analysed and this requires a team of subject matter experts who can effectively detect risks related to drugs and assist in maintaining the drug into the market throughout its lifecycle by constantly updating their risk management plans for patients' safety and well-being.

Asia is a continent which embraces a range of cultural, geographical and medical practices. Thus, it is a challenge to unify and standardize pharmacovigilance in Asia. The West is more advance in relation to the concept of Pharmacovigilance while Asian countries still lag behind. As a result of the rapid increase in clinical trials and clinical research activities in Asia, there is a great need to identify and implement effective pharmacovigilance practices.
